• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

OrbiMed

CoreMap gains $10.5M in Series A round

September 17, 2020 By Nancy Crotti

Burlington, Vt.-based startup CoreMap has secured $10.5 million in a Series A funding round led by Qure Ventures. Founded in 2016, CoreMap is taking aim at atrial fibrillation (AF) with technology designed to map complex arrhythmias inside the heart. The company’s patented system combines an electrode pair design in a high-density array configuration with algorithm-driven […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Funding Roundup Tagged With: CoreMap, FifthFocus/HRMG Investments, MassMEDIC, OrbiMed, Qure Ventures

OrbiMed founder Isaly lodges defamation suit against newspaper, reporter

October 22, 2018 By Brad Perriello

OrbiMed founder Sam Isaly sued the newspaper and reporter who published a story last year about his alleged sexual harassment of women employed at his his private equity fund. Reporter Damien Garde’s story, which ran Dec. 5, 2017, on the Boston Globe‘s STAT website, quoted six former employees who accused Isaly of routinely demeaning and harassing […]

Filed Under: Featured, Legal News Tagged With: OrbiMed

Orbimed founder Isaly resigns on harassment accusations

April 30, 2018 By Brad Perriello

OrbiMed founder and managing partner Sam Isaly made it official last week when he relinquished control of the private equity fund in the wake of sexual harassment allegations lodged by several former employees. Six former employees accused Isaly, a 72-year-old investor long revered in the biotech community for his ability to pick stocks, of routinely demeaning and […]

Filed Under: Wall Street Beat Tagged With: OrbiMed, Personnel Moves, Venture Capital/Private Equity

OrbiMed founder Isaly out after harassment allegations

December 8, 2017 By Brad Perriello

OrbiMed founder and managing partner Sam Isaly yesterday stepped down in the wake of sexual harassment allegations lodged by several former employees of the healthcare hedge fund. In a statement released last night, New York City-based OrbiMed said Isaly is leaving “pursuant to years-long succession planning discussions” and did not address the accusations from six women, first […]

Filed Under: Wall Street Beat Tagged With: OrbiMed, Venture Capital/Private Equity

Report: Investors review hedge fund involvement in wake of harassment allegations against Orbimed founder Isaly

December 7, 2017 By Brad Perriello

Institutional investors with positions in OrbiMed are reportedly reviewing their involvement with the healthcare hedge fund after sexual harassment allegations surfaced against founder and managing partner Sam Isaly. Six former employees of biotech hedge fund accused Isaly, a 72-year-old investor long revered in the biotech community for his ability to pick stocks, of routinely demeaning and harassing women with […]

Filed Under: Wall Street Beat Tagged With: OrbiMed, Venture Capital/Private Equity

Report: OrbiMed founder Sam Isaly harassed women for years, according to former employees

December 6, 2017 By Sarah Faulkner

Several former employees of biotech hedge fund OrbiMed have alleged that Sam Isaly, the firm’s founder & managing partner, sexually harassed his female colleagues for years, according to an investigation by STAT. Isaly is a 72-year-old investor who has long been revered among the biotech community for his ability to pick stocks. But at OrbiMed, former […]

Filed Under: Biotech, Wall Street Beat Tagged With: OrbiMed

Orbimed closes $551m Asia-focused healthcare fund

September 7, 2017 By Fink Densford

OrbiMed said this week it closed its 3rd Asian-focused healthcare private equity fund, having raised approximately $551 million in capital commitments. The new fund, the Asia Partners III, is slated to invest “broadly across the Asian healthcare industry,” focusing on growth stage product and services-oriented companies in China and India, according to the investment firm. […]

Filed Under: Business/Financial News Tagged With: OrbiMed, Venture Capital/Private Equity

ViewRay raises $14m in private placement

August 22, 2016 By Brad Perriello

ViewRay (NSDQ:VRAY) said today that it raised nearly $14 million in a private placement as it gears up to launch its MRIdian linear accelerator, saying it expects to win regulatory nods in the U.S. and overseas by the end of the year. Cleveland-based ViewRay said the round was led by existing backers OrbiMed Advisors, Xeraya Capital and Kearny Venture […]

Filed Under: Funding Roundup, Imaging, Wall Street Beat Tagged With: CRG, Kearny Venture Partners, OrbiMed, Venture Capital/Private Equity, ViewRay Inc., Xeraya Capital

OrbiMed launches $950m healthcare fund

December 23, 2015 By Brad Perriello

OrbiMed said it closed another venture capital fund worth $950 million that it plans to deploy on about 30 companies in the medical device, biopharmaceutical, diagnostics and healthcare IT markets. The New York-based VC giant said its OrbiMed Private Investments VI fund will put up investments ranging from $10 million to $75 million. Last year OrbiMed floated a $924 […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: OrbiMed, Venture Capital/Private Equity

OrbiMed floats $924m healthcare fund

February 3, 2015 By Brad Perriello Leave a Comment

OrbiMed floats $924m healthcare fund

OrbiMed said today that it raised a $924 million fund to invest in healthcare companies, following the flotation of a $735 million fund back in November 2013.

Filed Under: Funding Roundup, News Well Tagged With: OrbiMed

Astute Medical to receive up to $30M from CRG for kidney-injury test | Medtech funding for the week of October 13, 2014

October 17, 2014 By MassDevice

FDA nod triggers $30m milestone for Astute Medical

October 10, 2014 by Alexander Soule

Filed Under: Funding Roundup, News Well, Respiratory Tagged With: Astute Medical, c2 Therapeutics, CRG, Frontline BioVentures, Medical Alley, MID Labs, OrbiMed, Ortho-Clinical Diagnostics, Softbank China Venture Capital, Sungent BioVenture

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS